Tag: pharmaceutical

  • OpenAI : Accelerating life sciences research

    Source URL: https://openai.com/index/accelerating-life-sciences-research-with-retro-biosciences Source: OpenAI Title: Accelerating life sciences research Feedly Summary: Discover how a specialized AI model, GPT-4b micro, helped OpenAI and Retro Bio engineer more effective proteins for stem cell therapy and longevity research. AI Summary and Description: Yes Summary: The text highlights the utilization of a specialized AI model, GPT-4b micro, in…

  • Slashdot: Google DeepMind’s Spinoff Company ‘Very Close’ to Human Trials for Its AI-Designed Drugs

    Source URL: https://science.slashdot.org/story/25/07/06/2124226/google-deepminds-spinoff-company-very-close-to-human-trials-for-its-ai-designed-drugs Source: Slashdot Title: Google DeepMind’s Spinoff Company ‘Very Close’ to Human Trials for Its AI-Designed Drugs Feedly Summary: AI Summary and Description: Yes Summary: The text illustrates the significant advancements in AI-driven drug discovery, particularly highlighting Isomorphic Labs’ plans to initiate human clinical trials using AI-designed drugs. This aligns closely with the…

  • Cloud Blog: Graduating the Google for Startups Accelerator: AI First in Europe & Israel

    Source URL: https://cloud.google.com/blog/topics/startups/graduating-ai-first-accelerator-in-europe-and-israel/ Source: Cloud Blog Title: Graduating the Google for Startups Accelerator: AI First in Europe & Israel Feedly Summary: Today, we’re incredibly proud to announce the graduation of the latest cohort from the Google for Startups Accelerator: AI First from Europe & Israel! This milestone marks the culmination of an intensive three-months journey…

  • Slashdot: FDA To Use AI In Drug Approvals To ‘Radically Increase Efficiency’

    Source URL: https://science.slashdot.org/story/25/06/11/015216/fda-to-use-ai-in-drug-approvals-to-radically-increase-efficiency?utm_source=rss1.0mainlinkanon&utm_medium=feed Source: Slashdot Title: FDA To Use AI In Drug Approvals To ‘Radically Increase Efficiency’ Feedly Summary: AI Summary and Description: Yes Summary: The FDA’s new strategy involves utilizing AI, specifically a large-language model named Elsa, to enhance the efficiency of drug and device approval processes. While promising, some limitations and challenges remain…

  • New York Times – Artificial Intelligence : Isomorphic Labs, Google’s A.I. Drug Business, Raises Money From Thrive

    Source URL: https://www.nytimes.com/2025/03/31/business/dealbook/isomorphic-google-thrive-investment.html Source: New York Times – Artificial Intelligence Title: Isomorphic Labs, Google’s A.I. Drug Business, Raises Money From Thrive Feedly Summary: The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer. AI Summary and Description: Yes Summary: The text discusses Google’s advancements…

  • Slashdot: DNA of 15 Million People For Sale In 23andMe Bankruptcy

    Source URL: https://science.slashdot.org/story/25/03/24/2022232/dna-of-15-million-people-for-sale-in-23andme-bankruptcy?utm_source=rss1.0mainlinkanon&utm_medium=feed Source: Slashdot Title: DNA of 15 Million People For Sale In 23andMe Bankruptcy Feedly Summary: AI Summary and Description: Yes Summary: The text discusses 23andMe’s Chapter 11 bankruptcy filing, raising significant concerns about the security and privacy of genetic information following a major data breach. The financial turmoil highlights the vulnerabilities associated…

  • Cloud Blog: Accelerating AI in healthcare using NVIDIA BioNeMo Framework and Blueprints on GKE

    Source URL: https://cloud.google.com/blog/products/ai-machine-learning/accelerate-ai-in-healthcare-nvidia-bionemo-gke/ Source: Cloud Blog Title: Accelerating AI in healthcare using NVIDIA BioNeMo Framework and Blueprints on GKE Feedly Summary: The quest to develop new medical treatments has historically been a slow, arduous process, screening billions of molecular compounds across decade-long development cycles. The vast majority of therapeutic candidates do not even make it…